VINORELBINE AN vinorelbine (as tartrate) 10 mg/1 mL concentrated injection vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

vinorelbine tartrate, Quantity: 13.85 mg (Equivalent: vinorelbine, Qty 10 mg)

Disponível em:

Amneal Pharma Australia Pty Ltd

DCI (Denominação Comum Internacional):

Vinorelbine tartrate

Forma farmacêutica:

Injection, concentrated

Composição:

Excipient Ingredients: water for injections

Via de administração:

Intravenous Infusion

Unidades em pacote:

Pack of 1 x 1 mL vial, Pack of 10 x 1 mL vials, Pack of 5 x 1 mL vials

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Resumo do produto:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Licence status A

Data de autorização:

2012-01-18